Aripiprazole

• ATC Code
• Indication
• NEMLC Recommendation
• Review Indicators
• Date Ratified

ATC CODE

• N05AX12

INDICATION

• Schizophrenia in children.

NEMLC RECOMMENDATION

• Approved - for use as a third-line agent in children with psychotic disorders who are intolerant to typical and atypical antipsychotic agents with:
  • Obesity, defined as BMI ≥ 30 or age appropriate measures, or
  • Excessive weight gain, if associated with metabolic syndrome in adherent patients on other atypical antipsychotics, not responsive to other interventions (e.g. dietary management and/or physical exercise).

Aripiprazole be initiated, in these cases, in consultation with or, where available, by a subspecialist (i.e. child and adolescent psychiatrist)

REVIEW INDICATORS

• New evidence of efficacy in children and adolescents.

DATE RATIFIED

• 29 November 2013